Showing 1011-1020 of 1043 results for "".
- Rates and Outcomes of Concussion Affected by Intensity Hits and Family History of Dementiahttps://practicalneurology.com/news/rates-and-outcomes-of-concussion-affected-by-intensity-hits-and-family-history-of-dementia/2469993/Susceptibility to concussion may have a genetic component, and intensity of head impacts may better predict future consequences (eg, chronic traumatic encephalopathy [CTE]) better than years of play or number of hits to the head. In a study of active boxers and mixed martial arts
- Cognitive Symptoms After Mild COVID-19 Correlated With Immunologic Biomarkers in Cerebrospinal Fluidhttps://practicalneurology.com/news/cognitive-symptoms-after-mild-covid-19-correlated-with-immunologic-biomarkers-in-cerebrospinal-fluid/2469864/A clinical study found higher levels of cerebrospinal fluid (CSF) immune activation and immunovascular markers in people with cognitive effects of post-acute of SARS-CoV-2 infection (PASC), also known as long COVID. C-reactive protein (CRP) and amyloid A levels were significantly higher in those
- New Balloon Guide Catheter for Acute Ischemic Stroke Treatmenthttps://practicalneurology.com/news/new-balloon-guide-catheter-for-acute-ischemic-stroke-treatment/2469818/A next generation balloon guide catheter (Emboguard; CERENOVUS, Irvine, CA) to be used in endovascular procedures for individuals with acute ischemic stroke, has become available. The balloon guide catheters increase first pass recanalization, reduce procedure time, and reduce the odds of c
- Rimegepant Now Approved for Both Acute and Preventive Migraine Treatmenthttps://practicalneurology.com/news/rimegepant-now-approved-for-both-acute-and-preventive-migraine-treatment/2469603/The FDA has approved rimegepant (Nurtec; Biohaven Pharmaceuticals, New Haven, CT) for the additional indication of preventive treatment of migraine. The approval for preventative migraine treatment makes rimegepant the first drug approved to treat acute migraine attacks and help prevent future mi
- Potential Pediatric Use of New Migraine Therapieshttps://practicalneurology.com/news/potential-pediatric-use-of-new-migraine-therapies/2469437/Over the past 10 years multiple new treatments have been approved for use in adults. However, there has been little improvement in treatments specifically indicated for treatment of migraine in children, and very little data on the effects of these medications in children are available. At the Vi
- Mortality of Unruptured Brain Aneurysms Reduced By Advances in Treatmenthttps://practicalneurology.com/news/mortality-of-unruptured-brain-aneurysms-reduced-by-advances-in-treatment/2469345/According to the new findings presented at the Society of Neurointerventional Surgery (SNIS) 17th Annual Meeting, mortality rates after treatment of unruptured intracranial aneurysms have substantially decreased over the past decade. In this observational re
- Rare Genetic Mutations Linked to Parkinson Disease Identified in Pilot Studyhttps://practicalneurology.com/news/rare-genetic-mutations-linked-to-parkinson-disease-identified-in-pilot-study/2469313/In the PD GENEration: Mapping the Future of Parkinson's Disease pilot study (NCT04057794), approximately 17% of all participants tested positive for genetic mutations linked to Parkinson
- The AAN Gives Feedback on Changed Policies to Better Care for Individuals with Neurologic Conditionshttps://practicalneurology.com/news/the-aan-gives-feedback-on-changed-policies-to-better-care-for-individuals-with-neurologic-conditions/2469199/In response to legislation recently passed by Congress, the American Academy of Neurology (AAN) offers room for further improvement on changed policies and recommendations made by neurologists for their patients. The Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 (t
- Multiple Neurology Advocacy Groups Sign Statement Urging Congress to Protect Those With Chronic Conditions During COVID-19 Pandemichttps://practicalneurology.com/news/multiple-neurology-advocacy-groups-sign-statement-urging-congress-to-protect-those-with-chronic-conditions-during-covid-19-pandemic/2469192/Organizations implore the US Senate to pass the US House-approved coronavirus bill as soon as possible and take additional critical steps. These organizations represent millions of individuals diagnosed with serious health conditions who are concerned for their safety. In a letter to the US Senat
- More Sites Offer Free Parkinson Disease Genetic Testing and Counselinghttps://practicalneurology.com/news/more-sites-offer-free-parkinson-disease-genetic-testing-and-counseling/2469122/The Parkinson's Foundation has added 5 new sites for PD GENEration: Mapping the Future of Parkinson's Disease, a first-of-its-kind national initiative that offers free genetic testing and counseling for clinically relevant Parkinson disease (PD)-related genes. The new sites include Massac